{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:45:00Z","timestamp":1783529100292,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The association between psoriasis, chronic kidney disease (CKD) and mortality remains unclear. This study aimed to examine the combined impact of psoriasis and CKD on mortality in a representative sample of US adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The data for this analysis came from 13\u2009208 participants of the National Health and Nutrition Examination Survey conducted between 2003\u201306 and 2009\u201314. Psoriasis was determined through self-reported questionnaire data, while CKD was defined as an estimated glomerular filtration rate (eGFR) &amp;lt;60\u00a0mL\/min\/1.73 m2 or urinary albumin to creatinine ratio (UACR) \u226530\u00a0mg\/g. A four-level variable was created using the information on psoriasis and CKD, and survival probability was estimated using the Kaplan\u2013Meier method. The survival analysis was conducted using weighted Cox proportional hazards regression models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In a 9.83-year average follow-up period, 539 deaths occurred, with a prevalence of psoriasis in CKD at 2.94% and an all-cause mortality rate of 33.30%. In the multivariable analyses, individuals with both psoriasis and CKD had hazard ratios (HRs) of 5.38 (95% CI 2.43\u201311.91) for all-cause mortality compared with those with neither psoriasis nor CKD. Participants with both psoriasis and low eGFR had an HR of 6.40 (95% CI 2.01\u201320.42), while those with both psoriasis and albuminuria had an HR of 5.30 (95% CI 2.24\u201312.52). A significant interaction between psoriasis, CKD and all-cause mortality was found in the fully adjusted model (P\u00a0=\u00a0.026), and a significant synergistic effect between psoriasis and albuminuria was discovered (P\u00a0=\u00a0.002). However, the interaction effects between psoriasis, low eGFR and all-cause mortality were only observed in the unadjusted model (P\u00a0=\u00a0.036).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Screening for psoriasis in individuals at risk for developing CKD may help in risk stratification for all-cause mortality related to psoriasis. The assessment of UACR may be useful in identifying psoriasis at increased risk for all-cause mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfad089","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T02:17:20Z","timestamp":1683944240000},"page":"2474-2484","source":"Crossref","is-referenced-by-count":18,"title":["Interaction effect of psoriasis and chronic kidney disease on the risk of all-cause mortality: a prospective cohort study of NHANES data"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2759-928X","authenticated-orcid":false,"given":"Jian","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-6911","authenticated-orcid":false,"given":"Han","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-4119","authenticated-orcid":false,"given":"Shixiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Beijing Chao-Yang Hospital, Capital Medical University , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"2023103100562189200_bib1","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","article-title":"A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases","volume":"34","author":"Jager","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100562189200_bib2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"2023103100562189200_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ekir.2019.12.003","article-title":"Preventing CKD in developed countries","volume":"5","author":"Luyckx","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2023103100562189200_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrneph.2013.254","article-title":"Psoriasis\u2014a risk factor for chronic kidney disease?","volume":"10","author":"Farmer","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2023103100562189200_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet North Am Ed"},{"key":"2023103100562189200_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-021-00590-y","article-title":"Psoriasis in patients with metabolic syndrome or type 2 diabetes mellitus: treatment challenges","volume":"22","author":"Pannu","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"2023103100562189200_bib7","doi-asserted-by":"crossref","first-page":"868277","DOI":"10.3389\/fimmu.2022.868277","article-title":"Psoriasis and cardiovascular diseases: an immune-mediated cross talk?","volume":"13","author":"Orlando","year":"2022","journal-title":"Front Immunol"},{"key":"2023103100562189200_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-015-3126-4","article-title":"Kidney disease and psoriasis: novel evidences beyond old concepts","volume":"35","author":"Visconti","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2023103100562189200_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","article-title":"Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study","volume":"78","author":"Chi","year":"2015","journal-title":"J Dermatol Sci"},{"key":"2023103100562189200_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bjd.13599","article-title":"Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study","volume":"173","author":"Chiu","year":"2015","journal-title":"Br J Dermatol"},{"key":"2023103100562189200_bib11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/bjd.20067","article-title":"Inflammatory skin diseases and the risk of chronic kidney disease: population-based case-control and cohort analyses","volume":"185","author":"Schonmann","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023103100562189200_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1159\/000522228","article-title":"Psoriasis and renal disorders: a large-scale population-based study in children and adults","volume":"238","author":"Friedland","year":"2022","journal-title":"Dermatology"},{"key":"2023103100562189200_bib13","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3390\/jcm10112356","article-title":"Proteinuria and psoriasis risk: a nationwide population-based study","volume":"10","author":"Bae","year":"2021","journal-title":"J Clin Med"},{"key":"2023103100562189200_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jaad.2019.08.011","article-title":"Psoriasis and mortality in the United States: data from the National Health and Nutrition Examination Survey","volume":"85","author":"Semenov","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2023103100562189200_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br J Dermatol"},{"key":"2023103100562189200_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2023103100562189200_bib17","first-page":"19","article-title":"KDIGO's 2012 Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease. Chapter","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2023103100562189200_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.ajkd.2013.03.003","article-title":"Definition and classification of kidney diseases","volume":"61","author":"Levey","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2023103100562189200_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ki.1984.57","article-title":"A solid phase fluorescent immunoassay for the measurement of human urinary albumin","volume":"25","author":"Chavers","year":"1984","journal-title":"Kidney Int"},{"key":"2023103100562189200_bib20","first-page":"438","article-title":"Chronic kidney disease in psoriasis: a cohort study","volume":"18","author":"Conti","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"2023103100562189200_bib21","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study","volume":"347","author":"Wan","year":"2013","journal-title":"BMJ"},{"key":"2023103100562189200_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12882-015-0101-x","article-title":"Periodontal disease, chronic kidney disease and mortality: results from the third National Health and Nutrition Examination Survey","volume":"16","author":"Ricardo","year":"2015","journal-title":"BMC Nephrol"},{"key":"2023103100562189200_bib23","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2023103100562189200_bib24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jaad.2019.12.043","article-title":"Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease","volume":"82","author":"Maghfour","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2023103100562189200_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000247420","article-title":"Relation between urinary albumin excretion and skin involvement in patients with psoriasis","volume":"185","author":"Cecchi","year":"1992","journal-title":"Dermatology"},{"key":"2023103100562189200_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1346-8138.2000.tb02230.x","article-title":"Is renal function altered in patients with psoriasis vulgaris?\u2014A short review","volume":"27","author":"Szepietowski","year":"2000","journal-title":"J Dermatol"},{"key":"2023103100562189200_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.02.018","article-title":"Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase","volume":"46","author":"Al-Harbi","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"2023103100562189200_bib28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int"},{"key":"2023103100562189200_bib29","first-page":"1","article-title":"Psoriasis-like inflammation induced renal dysfunction through the TLR\/NF-\u03baB signal pathway","volume":"2020","author":"Ren","year":"2020","journal-title":"Biomed Res Int"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad089\/50625993\/gfad089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/11\/2474\/52661020\/gfad089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/11\/2474\/52661020\/gfad089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:25:15Z","timestamp":1698733515000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/38\/11\/2474\/7161142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,5,12]]},"published-print":{"date-parts":[[2023,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad089","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,5,12]]}}}